G1 Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about news in G1 Therapeutics, Inc..

The service is free and you can unsubscribe at any time.

General | People (57) | Filings (59) | Investment rounds (8) | Stock | News

Industry: PHARMACEUTICAL PREPARATIONS [2834]

CIK Number: 0001560241
IRS Number: 263648180

G1 Therapeutics, Inc. is a publicly traded company

Trading symbol: GTHX

G1 Therapeutics, Inc. is on the market more than 5 years.

News

2017-10-16

G1 THERAPEUTICS (GTHX) Given $29.67 Consensus Price Target by Analysts
Dispatch Tribunal
A number of analysts have commented on GTHX shares. Zacks Investment Research cut shares of G1 THERAPEUTICS from a “hold” rating to a “sell” rating in a research report on Wednesday, October 11th.
G1 Therapeutics (GTHX) Reaches $24.49 After 6.00% Up Move; 1 Analysts Bullish ... - HuronReport

2017-10-15

EPS for G1 Therapeutics Inc (GTHX) Expected At $-0.56
WeeklyHub
Analysts await G1 Therapeutics Inc (NASDAQ:GTHX) to report earnings on November, 8. After $-1.09 actual earnings per share reported by G1 Therapeutics Inc for the previous quarter, Wall Street now forecasts -48.62 % EPS growth. The stock decreased ...
G1 Therapeutics Inc (GTHX) Analysts See $-0.56 EPS - KL Daily
RA Capital Management LLC Takes $46.81 Million Position in G1 THERAPEUTICS (GTHX) - The Ledger Gazette

2017-10-12

G1 THERAPEUTICS (GTHX) Lowered to “Sell” at Zacks Investment Research
StockNewsTimes
Zacks Investment Research downgraded shares of G1 THERAPEUTICS (NASDAQ:GTHX) from a hold rating to a sell rating in a research note published on Wednesday.
G1 Therapeutics Inc (GTHX) Share Activity Climbing in Session - JCTY News

2017-09-18

G1 Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes
GlobeNewswire (press release)
RESEARCH TRIANGLE PARK, N.C., Sept. 18, 2017 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ:GTHX), a clinical-stage oncology company, today announced that it has been added to the Russell 2000®, Russell 3000®, and Russell Microcap® ...

2017-09-13

What's Behind G1 Therapeutics Inc (GTHX)'s Movement
FLBC News
Needle moving action has been spotted in G1 Therapeutics Inc (GTHX) as shares are moving today on volatility 3.30% or 0.87 from the open.

2017-09-07

Somewhat Positive Press Coverage Somewhat Unlikely to Affect G1 THERAPEUTICS ...
The Ledger Gazette
G1 THERAPEUTICS logo Media stories about G1 THERAPEUTICS (NASDAQ:GTHX) have been trending somewhat positive this week, Accern Sentiment reports.
Analysts Set $29.67 Target Price for G1 THERAPEUTICS (GTHX) - StockNewsTimes

2017-08-31

G1 Therapeutics Inc (GTHX) Seeing Increased Action in Session
FLBC News
Shares of G1 Therapeutics Inc (GTHX) have seen the needle move 4.14% or 0.77 in the most recent session. The NASDAQ listed company saw a recent bid of $19.39 on 29919 volume.

G1 Therapeutics, Inc. address

79 T.W. ALEXANDER DRIVE
4501 RESEARCH COMMONS, SUITE 100
RESEARCH TRIANGLE PARK
27709

G1 Therapeutics, Inc. address

P. O. BOX # 110341
RESEARCH TRIANGLE PARK
27709

G1 Therapeutics, Inc. address

79 T.W. ALEXANDER DRIVE
4501 RESEARCH COMMONS, SUITE 100
RESEARCH TRIANGLE PARK
27709

Former name

Former name of this company was G-Zero Therapeutics, Inc., date of change: 2012-10-12.

Company jurisdiction

DELAWARE

Entity type

Corporation

Earliest known filing

October 2012

Latest known filing

August 2017

Company filings

SEC filings are a great source of information for companies including investments, company events, and all sorts of other information.

G1 Therapeutics, Inc. has 59 filings. View G1 Therapeutics, Inc. filings.

Quarterly Reports

Latest company events

Investment Rounds

G1 Therapeutics, Inc. recieved 8 investments.

People

We have found 57 people related to G1 Therapeutics, Inc..

Similar companies

G1 Enterprises, LLC, G1 EXECUTION SERVICES, LLC, G10-Rosseau Special Situations Fund (US) LP, G14M2 HHC, L.L.C., G1R Florida, LLC, G1R Mass, LLC